塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/12/21 | 1,470 | 1,471 | 1,444 | 1,457 | -4 | -0.3% | 1,907,900 |
2012/12/20 | 1,459 | 1,481 | 1,456 | 1,461 | -1 | -0.1% | 2,457,500 |
2012/12/19 | 1,454 | 1,518 | 1,451 | 1,462 | +19 | +1.3% | 4,199,700 |
2012/12/18 | 1,388 | 1,448 | 1,384 | 1,443 | +61 | +4.4% | 3,449,200 |
2012/12/17 | 1,369 | 1,386 | 1,355 | 1,382 | +33 | +2.4% | 1,902,700 |
2012/12/14 | 1,362 | 1,373 | 1,346 | 1,349 | -15 | -1.1% | 3,810,500 |
2012/12/13 | 1,382 | 1,383 | 1,357 | 1,364 | -13 | -0.9% | 1,177,300 |
2012/12/12 | 1,393 | 1,393 | 1,368 | 1,377 | -7 | -0.5% | 980,300 |
2012/12/11 | 1,398 | 1,399 | 1,382 | 1,384 | -9 | -0.6% | 1,224,800 |
2012/12/10 | 1,397 | 1,400 | 1,384 | 1,393 | +10 | +0.7% | 868,000 |
2012/12/07 | 1,397 | 1,400 | 1,381 | 1,383 | -10 | -0.7% | 1,152,500 |
2012/12/06 | 1,390 | 1,406 | 1,390 | 1,393 | +6 | +0.4% | 1,076,000 |
2012/12/05 | 1,376 | 1,396 | 1,376 | 1,387 | +2 | +0.1% | 921,200 |
2012/12/04 | 1,382 | 1,399 | 1,369 | 1,385 | -3 | -0.2% | 1,209,500 |
2012/12/03 | 1,405 | 1,405 | 1,383 | 1,388 | -8 | -0.6% | 973,900 |
2012/11/30 | 1,380 | 1,402 | 1,378 | 1,396 | +19 | +1.4% | 1,979,700 |
2012/11/29 | 1,369 | 1,380 | 1,357 | 1,377 | +21 | +1.5% | 1,114,700 |
2012/11/28 | 1,361 | 1,374 | 1,354 | 1,356 | -4 | -0.3% | 1,013,600 |
2012/11/27 | 1,323 | 1,371 | 1,322 | 1,360 | +43 | +3.3% | 2,217,100 |
2012/11/26 | 1,349 | 1,353 | 1,314 | 1,317 | -26 | -1.9% | 2,672,500 |
2012/11/22 | 1,369 | 1,372 | 1,320 | 1,343 | -26 | -1.9% | 2,183,500 |
2012/11/21 | 1,372 | 1,380 | 1,356 | 1,369 | ±0 | ±0% | 1,236,100 |
2012/11/20 | 1,390 | 1,391 | 1,361 | 1,369 | -21 | -1.5% | 1,888,200 |
2012/11/19 | 1,377 | 1,395 | 1,370 | 1,390 | +27 | +2% | 1,395,300 |
2012/11/16 | 1,346 | 1,363 | 1,325 | 1,363 | +19 | +1.4% | 1,812,200 |
2012/11/15 | 1,349 | 1,357 | 1,336 | 1,344 | -4 | -0.3% | 1,240,200 |
2012/11/14 | 1,326 | 1,389 | 1,325 | 1,348 | +29 | +2.2% | 2,967,600 |
2012/11/13 | 1,320 | 1,331 | 1,309 | 1,319 | -7 | -0.5% | 1,076,300 |
2012/11/12 | 1,327 | 1,339 | 1,323 | 1,326 | -17 | -1.3% | 978,700 |
2012/11/09 | 1,330 | 1,364 | 1,320 | 1,343 | +2 | +0.1% | 1,876,700 |
2012/11/08 | 1,373 | 1,381 | 1,333 | 1,341 | -45 | -3.2% | 2,038,900 |
2012/11/07 | 1,390 | 1,396 | 1,378 | 1,386 | -6 | -0.4% | 1,616,600 |
2012/11/06 | 1,355 | 1,409 | 1,351 | 1,392 | +44 | +3.3% | 3,694,200 |
2012/11/05 | 1,335 | 1,361 | 1,329 | 1,348 | +8 | +0.6% | 1,743,400 |
2012/11/02 | 1,302 | 1,362 | 1,299 | 1,340 | +8 | +0.6% | 2,749,200 |
2012/11/01 | 1,330 | 1,342 | 1,314 | 1,332 | +8 | +0.6% | 1,257,700 |
2012/10/31 | 1,340 | 1,345 | 1,315 | 1,324 | -26 | -1.9% | 1,848,500 |
2012/10/30 | 1,275 | 1,371 | 1,273 | 1,350 | +76 | +6% | 5,036,500 |
2012/10/29 | 1,270 | 1,278 | 1,247 | 1,274 | +2 | +0.2% | 1,905,800 |
2012/10/26 | 1,280 | 1,290 | 1,264 | 1,272 | -3 | -0.2% | 1,723,400 |
2012/10/25 | 1,258 | 1,277 | 1,251 | 1,275 | +17 | +1.4% | 1,469,100 |
2012/10/24 | 1,259 | 1,269 | 1,253 | 1,258 | -12 | -0.9% | 1,211,800 |
2012/10/23 | 1,270 | 1,277 | 1,266 | 1,270 | +10 | +0.8% | 1,221,600 |
2012/10/22 | 1,243 | 1,264 | 1,240 | 1,260 | +9 | +0.7% | 826,700 |
2012/10/19 | 1,245 | 1,254 | 1,242 | 1,251 | -2 | -0.2% | 1,047,400 |
2012/10/18 | 1,242 | 1,258 | 1,234 | 1,253 | +23 | +1.9% | 2,204,500 |
2012/10/17 | 1,259 | 1,259 | 1,217 | 1,230 | -25 | -2% | 2,869,300 |
2012/10/16 | 1,250 | 1,270 | 1,238 | 1,255 | +8 | +0.6% | 1,641,000 |
2012/10/15 | 1,240 | 1,250 | 1,234 | 1,247 | +9 | +0.7% | 1,445,300 |
2012/10/12 | 1,222 | 1,249 | 1,220 | 1,238 | +26 | +2.1% | 2,480,000 |
3101~
3150
件表示中 / 3774件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,900円 | +20.9% | +10.6% | 2.58% | 12.10倍 | 1.60倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 793,400円 | +2.2% | +28.0% | 1.76% | 12.70倍 | 1.54倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 164,300円 | +0.9% | +380.2% | 4.75% | 22.63倍 | 1.95倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 469,900円 | +0.1% | -3.4% | 3.40% | 31.94倍 | 1.58倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 260,500円 | -3.5% | -11.3% | 2.30% | 23.93倍 | 1.62倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム